Nordmark 2005.

Methods	Double blind RCT 6 months (open label continuation for further 6 months)
Participants	Total: 37* (4 dropped out and not included in analysis, 41 recruited) Sex: female Ethnicity: not stated Mean age: 47 to 48 years (selection involved stratification into 2 age group of equal size)
Interventions	Grp 1: DHEA 20‐30mg/dy Grp 2: placebo
Outcomes	Stated primary: HRQoL and behaviour (various tools) SLEDAI; SLICC; Bone mineral density; biological markers;
Notes	Funding: various non industry sources
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Low risk	A ‐ Adequate